Key takeaways:
Wegovy (semaglutide) is an injectable medication for weight loss. It’s also approved to lower the risk of serious cardiovascular problems in adults with heart disease and a larger body size.
Wegovy is made to last a long time in the body, which is why you inject it once a week. Because of this, it takes about 5 to 7 weeks to get most of the Wegovy out of your system after your last dose. This is an important consideration if you’re planning to become pregnant.
You can’t flush Wegovy out of your system. If you think you’ve injected too much, contact your healthcare team or Poison Control right away for guidance.
Whether you’re starting Wegovy (semaglutide) or curious if Wegovy is right for you, it’s natural for questions to arise. Your healthcare team will cover common topics, such as your specific dosage, potential side effects, and how to inject Wegovy.
But you still may have other questions. For example, how long does Wegovy stay in your system if you need to stop taking it? Can you skip it for a week? Is it possible to flush Wegovy out of your system? We answer these and other common questions about Wegovy below.
Wegovy is used for weight loss in adults and adolescents ages 12 and older who are considered to be obese. Adults who are considered to be overweight and have at least one weight-related health condition (such as high blood pressure or Type 2 diabetes) are also eligible for Wegovy.
Save every month on GLP-1 meds with GoodRx
Save an average of $235 on FDA-approved GLP-1s like Ozempic and Zepbound.
For adults with heart disease who are considered to be overweight or obese, Wegovy is approved to lower the risk of major adverse cardiovascular events, or MACE (heart attack, stroke, or cardiovascular death).
Wegovy is also being studied for several other uses, including a certain type of heart failure in people with and without diabetes, and metabolic dysfunction-associated steatohepatitis (also called non-alcoholic steatohepatitis, or NASH).
Wegovy was made to last a long time in the body. This is why you only need to inject a dose once a week. In fact, it takes about 7 days for your body to remove half of it (called its half-life). Because of this, Wegovy tends to stay in your system for 5 to 7 weeks after your last dose.
This information is important for a few reasons. First, Wegovy isn’t recommended during pregnancy. Your care team will likely have you stop taking it at least 2 months before you start trying to conceive.
No, you can’t flush Wegovy out of your system. If you accidentally inject too much, contact Poison Control at 1-800-222-1222 or your healthcare team for guidance. They can help monitor your symptoms and advise you on what to do next. But if any symptoms feel severe or life-threatening, go to the nearest ER.
Generally, yes. Higher doses of semaglutide, the main ingredient in Wegovy, tend to result in greater weight loss than lower doses. Because of this, the target maintenance dose is 2.4 mg weekly for most people. And a higher, 7.2 mg dose is currently being studied to see if it results in even more weight loss.
However, you won’t start with the 2.4 mg Wegovy dose right away. Instead, you’ll start with 0.25 mg once weekly. Every 4 weeks, your dose will likely be increased until you reach 2.4 mg weekly. If you can’t tolerate this dose, you may be able to stick with 1.7 mg weekly instead.
You should inject Wegovy every week for best results. But if you happen to skip a week for any reason, don’t fret. You can resume your usual dosage schedule the following week. Be sure to keep at least 48 hours in between your last dose and next dose.
However, skipping 2 or more weeks of Wegovy may be more of an issue. In this case, you should contact your prescriber. They may have you resume your usual schedule or restart Wegovy at a lower dose and work your way back up.
What to expect: Wegovy (semaglutide) is known to cause unpleasant side effects, such as nausea and bloating, that can make it difficult to tolerate. Learn more about potential Wegovy side effects and what you can do to find relief.
Stopping treatment: For most people, Wegovy is a medication that’s meant to be taken long term. But what happens if you stop taking Wegovy?
A natural boost: Medications like Wegovy work by mimicking the effects of a gut hormone called glucagon-like peptide-1 (GLP-1). But did you know that there are foods and supplements that can increase GLP-1 naturally?
There’s no direct interaction between alcohol and Wegovy. However, you might not have the same desire to drink with Wegovy. And alcohol could worsen certain Wegovy side effects, such as nausea, vomiting, and stomach upset. What’s more, alcohol may counteract some of Wegovy’s body weight and heart health benefits, too.
Talk to your prescriber if you have questions about drinking alcohol with Wegovy. Since everyone responds to alcohol and medications differently, your prescriber can determine if this combination might be OK for you.
Yes. Wegovy requires a prescription from a licensed healthcare professional. It’s not available over the counter. You may see medications purported to be Wegovy (or semaglutide) being sold online without a prescription from research chemical companies — these products are not the same as Wegovy.
Not yet. Semaglutide is available as an oral pill called Rybelsus. But Rybelsus is only approved for Type 2 diabetes. It’s also currently available in doses that are much lower than the target maintenance dose of Wegovy. However, a Wegovy pill could be available in the near future.
Higher oral semaglutide doses are currently under FDA review for weight loss. Study findings suggest that the 25 mg dose may result in a comparable amount of weight loss as the Wegovy 2.4 mg injection.
Not typically. The needle inside the Wegovy injection pen is very small and thin, so the injections shouldn’t be painful. They’re also given subcutaneously, meaning that the needle goes in just under the skin.
But if you find that your Wegovy injections are uncomfortable, it may help to remove your injection pen from the refrigerator at least 30 minutes before your dose. Sometimes, injecting Wegovy cold can be more painful. Allowing it to come to room temperature may lessen potential discomfort.
Yes. Wegovy injection pens come with a needle already attached to the pen. The needle is hidden inside the needle cover, so you won’t see it. If your Wegovy pen comes with needles that you need to attach — it’s not real Wegovy.
Ozempic, another semaglutide injection, does come with separate needles. The needles are visible, and you’ll need to attach a new one each time you inject a dose of Ozempic.
Many people report feeling less hungry shortly after starting Wegovy, with some initial weight loss within the first 4 weeks. But more significant weight loss typically happens over weeks to months. Most people reach the recommended maintenance dose (2.4 mg weekly) by week 17 (about 4 months). At this point, weight loss tends to continue more steadily.
Keep in mind that how long Wegovy takes to work can vary from person to person. For best results, it should be combined with a nutritious diet and regular exercise.
Wegovy (semaglutide) is a once-weekly injection for weight loss and cardiovascular risk reduction. After your last Wegovy dose, it takes 5 to 7 weeks to clear most of it from your body. How long Wegovy stays in your system is important if you’re planning to become pregnant.
Wegovy requires a prescription. And unlike Ozempic (semaglutide), Wegovy pens already have a needle attached that’s hidden inside the needle cover. Wegovy injections shouldn’t hurt. But taking your injection pen out of the refrigerator at least 30 minutes before your dose can make them more comfortable.
Talk to your healthcare team if you have any questions or concerns about Wegovy.
ClinicalTrials.gov. (2025). A research study to see how semaglutide helps people with excess weight, lose weight (STEP UP) (STEP UP). National Library of Medicine.
Eren-Yazicioglu, C. Y., et al. (2021). Can GLP-1 be a target for reward system related disorders? A qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol. Frontiers in Behavioral Neuroscience.
Kosiborod, M. N., et al. (2023). Semaglutide in patients with heart failure with preserved ejection fraction and obesity. New England Journal of Medicine.
Kosiborod, M. N., et al. (2024). Semaglutide in patients with obesity-related heart failure and Type 2 Diabetes. New England Journal of Medicine.
Novo Nordisk. (2020). Semaglutide 2.4 mg shows superior weight loss versus placebo in the phase 3 trials STEP 2 and STEP 3, thereby successfully completing the programme.
Novo Nordisk. (2024). Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial.
Novo Nordisk. (2024). Wegovy [package insert].
Novo Nordisk. (2025). FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity. PRNewswire.
Organization of Teratology Information Specialists. (2023). Semaglutide. MotherToBaby.
Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.